Alx Oncology Holdings
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -150 | -191 | ||
EBITDA | -17,446 | -22,314 | -21,583 | -25,353 |
EBIT | -17,596 | -22,465 | -21,736 | -25,544 |
Net Income | -17,927 | -22,848 | -22,144 | -25,949 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,698 | -19,029 | -17,149 | -23,453 |
Cash | 32,284 | 16,373 | 23,442 | 19,302 |
Basic Shares | 54,283 | 54,283 | 53,577 | 53,445 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -872 | -836 | -1,466 | |
EBITDA | -99,387 | -132,249 | -158,404 | -127,094 |
EBIT | -100,093 | -133,121 | -159,240 | -127,436 |
Net Income | -101,695 | -134,850 | -160,805 | -123,482 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -314,779 | |||
Free Cash Flow | -84,354 | -122,359 | -131,638 | -90,650 |
Cash | 16,373 | 17,567 | 22,406 | 48,822 |
Basic Shares | 53,658 | 52,174 | 42,987 | 40,699 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.15 |
2025-12-31 | -$0.36 |
2025-09-30 | -$0.41 |
2025-06-30 | -$0.44 |